What is the global market size of Office-Based Labs Market?

Office-based Labs Market size was valued at USD 39.77 billion in 2021 and is poised to grow from USD 43.09 billion in 2022 to USD 88.77 billion by 2030, growing at a CAGR of 8.36% in the forecast period (2023-2030).

Global Office-based Labs Market Size, Share, Growth Analysis, By Modality(Single-specialty labs, multi-specialty labs), By Service(Peripheral vascular intervention, endovascular interventions), By Specialists(Vascular surgeons, ophthalmology) - Industry Forecast 2024-2031

Report ID: SQSG35B2030 | Region: Global | Published Date: February, 2024
Pages: 157 | Tables: 98 | Figures: 76

Global Office-based Labs Market Regional Insights

In terms of market share and revenue, North America dominates the office-based labs market and will maintain its dominance throughout the forecast period. This is due to the high prevalence of various vascular diseases in this region, which will increase the demand for office-based labs. Because of the increasing burden of vascular and endovascular diseases in the US population, a high preference for treatment in outpatient settings indirectly generates demand for settings such as OBL.

Over the forecast period, Asia-Pacific is expected to have the highest CAGR. Factors such as the high prevalence of various vascular diseases, as well as growing awareness about the various benefits of office-based labs, would create lucrative growth prospects for the Asia-Pacific office-based labs market.

Global Office-based Labs Market Report Snapshots

License Type Top market research company in USA

File Type

$5,300

BUY NOW GET FREE SAMPLE

Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Office-based Labs Market size was valued at USD 39.77 billion in 2019 and is poised to grow from USD 43.09 billion in 2023 to USD 88.77 billion by 2031, growing at a CAGR of 8.36% in the forecast period (2024-2031).

This vendor landscape of the market can be divided into three distinct sectors: medical imaging device manufacturers, vascular intervention device manufacturers, and service providers who provide end-to-end services to physicians for lab setup. The service providers are focused on enhancing their range of services and undertake initiatives, such as partnerships & mergers, and acquisitions, to achieve the dominance in the market. Surgery Partners entered into a strategic partnership with UCI Health to develop & expand access to outpatient surgical facilities and enhance the quality of life of patients. This scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. 'Danaher Corporation', 'Dentsply Sirona', '3M ESPE', 'GC Corporation', 'Zimmer Biomet Holdings Inc.', 'Ivoclar Vivadent AG', 'Planmeca Oy', 'Ultradent Products Inc.', 'VOCO GmbH', 'Septodont Holding', 'VITA Zahnfabrik H. Rauter GmbH & Co. KG', 'KaVo Kerr Corporation', 'COLTENE Group', 'DentalEZ Group', 'Shofu Dental Corporation', 'Tokuyama Dental Corporation', 'Kuraray Noritake Dental Inc.', 'BEGO GmbH & Co. KG', 'Henry Schein, Inc.', 'Patterson Companies, Inc.'

Overall satisfaction rates with office-based lab services are at over 97%. Patients are also very satisfied because of the quality of the staff and streamlined services at OBLs. Office-base labs have highly qualified specialists and technologists. Besides this, such labs also maintain the records of their patients in a proper manner to provide quality care. Therefore, smooth workflow at OBLs and high satisfaction rates among patients will expand the office-based lab market size over the coming years.

Any technology that improves the safety and efficacy of same-day intervention allows for the expansion of procedures in freestanding facilities. CTO crossing has been a significant market advance. It will cross lower extremity artery long CTOs predictably, effectively, and efficiently. Depending on the plaque composition and lesion characteristics, various devices can be used. Crossing is usually successful with preparatory devices such as specialty wires, crossing catheters, or atherectomy devices. When the other devices are unable to cross, a reliable re-entry device is critical because it can be guided through the subintimal space, around the occlusion, and back to the true lumen. The ability to provide multiple crossing options for the complex CTO environment requiring treatment is critical to intervention success.

Feedback From Our Clients

"We have purchased recently a report from SkyQuest Technology, and we are happy to inform you that this report was so useful and practical for our team. Skyquest Team was very active and our queries were followed up completely.It was amazing. "

- Mr. Ali Zali, Commercial Director, ICIIC Iran.

Global Office-based Labs Market Size, Share, Growth Analysis, By Modality(Single-specialty labs, multi-specialty labs), By Service(Peripheral vascular intervention, endovascular interventions), By Specialists(Vascular surgeons, ophthalmology) - Industry Forecast 2024-2031

Global Office-based Labs Market Regional Insights

Global Office-based Labs Market Report Snapshots

Want to customize this report?

FAQs

What is the global market size of Office-based Labs Market?

Who are the key vendors in the Global Office-based Labs Market?

What is the key driver of Global Office-based Labs Market?

What is the key market trend for Global Office-based Labs Market?

Which region accounted for the largest share in Global Office-based Labs Market?

Request Free Customization

Related Reports

Feedback From Our Clients

$5,300